MGTX
MeiraGTx Holdings plc
NASDAQ · Healthcare · Biotechnology · US
$9.45
+1.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 31.46x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 28.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- 12.43x
- PEG TTM
- —
- Price / book
- 4.21x
- Price / sales
- 2.28x
- Price / cash flow
- 66.30x
Enterprise value
- Enterprise value
- $877.0M
- EV / sales
- 2.21x
- EV / EBITDA
- 3.34x
- EV / EBIT
- 4.77x
- Market cap
- $907.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026